Fortis Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Fortis Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) (NCT03650491) | Fortis Therapeutics, Inc. | 2019-04-03 |
| A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT03575819) | Fortis Therapeutics, Inc. | 2019-02-04 |
Track Fortis Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.